DISCUSSION "Successfully slowing Alzheimer's disease is within reach"
Sign in to Spring ITAPA 2025
Matej Mišík
He studied economics with a focus on competition and regulation in healthcare at Tilburg University and Vienna University of Economics and Business. For the other four years he headed the analytical unit of the Ministry of Health, the Institute of Health Analyses, served as a member of the supervisory boards of the The National Institute of Cardiovascular Diseases and Eastern Slovak Institute of Heart and Vascular Diseases cardiac institutes, represented Slovakia at the OECD and European Commission health forums. Currently, he works at HEPII (Health economics, policy and innovation institute) of Masaryk University and as a health consultant at LongTaal.
See more info about the speaker
Norbert Žilka
Norbert Žilka is currently the director of the Institute of Neuroimmunology of the SAS, where he held several research positions from 1998 to 2020. He specializes in research in the field of neurodegenerative diseases of the human brain and the preclinical and clinical development of drugs that modify this disease.
See more info about the speaker
Stanislav Šutovský
Professor Stanislav Šutovský, MD, PhD., is a leading expert in neurology, affiliated with the 1st Department of Neurology at Comenius University and University Hospital in Bratislava. He began building his expertise at the Institute of Neuroimmunology of the Slovak Academy of Sciences in Bratislava, further enhancing his skills through research placements at the Department of Neurology, Manchester Royal Infirmary in the United Kingdom, and at the Max Planck Institute for Structural Molecular Biology in Germany.
Dr. Šutovský is highly regarded in Alzheimer’s disease research, focusing on the development and validation of biomarkers for the early stages of Alzheimer’s and other forms of dementia. As the author or co-author of more than 40…
See more info about the speaker